OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epidemiologic perspectives on immunosuppressed populations and the immunosurveillance and immunocontainment of cancer
Eric A. Engels
American Journal of Transplantation (2019) Vol. 19, Iss. 12, pp. 3223-3232
Open Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

CD8+ T cell differentiation and dysfunction in cancer
Mary Philip, Andrea Schietinger
Nature reviews. Immunology (2021) Vol. 22, Iss. 4, pp. 209-223
Open Access | Times Cited: 666

A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplant
Naoka Murakami, Patrick M. Mulvaney, Melissa Danesh, et al.
Kidney International (2020) Vol. 100, Iss. 1, pp. 196-205
Open Access | Times Cited: 138

Towards targeting the breast cancer immune microenvironment
Michael A. Harris, Peter Savas, Balaji Virassamy, et al.
Nature reviews. Cancer (2024) Vol. 24, Iss. 8, pp. 554-577
Closed Access | Times Cited: 49

Vascular lesions of the head and neck: an update on classification and imaging review
Akshaar Brahmbhatt, Kamila Skalski, Alok A. Bhatt
Insights into Imaging (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 83

White Blood Cell Count, Neutrophil-to-Lymphocyte Ratio, and Incident Cancer in the UK Biobank
Minkyo Song, Barry I. Graubard, Erikka Loftfield, et al.
Cancer Epidemiology Biomarkers & Prevention (2024) Vol. 33, Iss. 6, pp. 821-829
Closed Access | Times Cited: 8

Transplant oncology and anti-cancer immunosuppressants
Dejun Kong, Jinliang Duan, Shiyi Chen, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 1

Virus-Driven Carcinogenesis
Yuichiro Hatano, Takayasu Ideta, Akihiro Hirata, et al.
Cancers (2021) Vol. 13, Iss. 11, pp. 2625-2625
Open Access | Times Cited: 51

De Novo Malignancy After Liver Transplantation: Risk Assessment, Prevention, and Management—Guidelines From the ILTS-SETH Consensus Conference
Jordi Colmenero, Parissa Tabrizian, Prashant Bhangui, et al.
Transplantation (2021) Vol. 106, Iss. 1, pp. e30-e45
Open Access | Times Cited: 48

Learning from the nexus of autoimmunity and cancer
Davide Mangani, Dandan Yang, Ana C. Anderson
Immunity (2023) Vol. 56, Iss. 2, pp. 256-271
Open Access | Times Cited: 17

Risk of Kaposi sarcoma after solid organ transplantation in the United States
Elizabeth K. Cahoon, Martha S. Linet, Christina A. Clarke, et al.
International Journal of Cancer (2018) Vol. 143, Iss. 11, pp. 2741-2748
Open Access | Times Cited: 58

Cancer incidence in immunocompromised patients: a single-center cohort study
Sabrina Ilham, Connor Willis, Kibum Kim, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 14

Overcoming barriers and stigma: new frontiers in solid organ transplantation for people with HIV
Kaitlyn Storm, Christine M. Durand
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 1
Closed Access | Times Cited: 5

Cancer risk in people living with HIV and solid organ transplant recipients: a systematic review and meta-analysis
Fengyi Jin, Claire M. Vajdic, I. Mary Poynten, et al.
The Lancet Oncology (2024) Vol. 25, Iss. 7, pp. 933-944
Closed Access | Times Cited: 5

Forty years of kidney transplantation: Insights into malignancies at a single center in Latin America
Pilar Musalem, Carolina Sáez-Vera
Transplant Immunology (2025), pp. 102216-102216
Closed Access

Cancer Mortality Among Solid Organ Transplant Recipients in the United States During 1987–2018
Jeanny Wang, Ruth M. Pfeiffer, Donnie Musgrove, et al.
Transplantation (2023)
Closed Access | Times Cited: 9

Cancer during HIV infection
Marinho Marques da Silva Neto, Carlos Brites, Álvaro H. Borges
Apmis (2020) Vol. 128, Iss. 2, pp. 121-128
Open Access | Times Cited: 27

Immunotherapy and the Spectrum of Kidney Disease: Should We Individualize the Treatment?
Sheila Bermejo, Mónica Bolufer, Mar Riveiro‐Barciela, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 15

Emerging Concepts in Managing Malignancy in Kidney Transplant Patients
Brittany Schreiber, Maen Abdelrahim, Ala Abudayyeh, et al.
Seminars in Nephrology (2022) Vol. 42, Iss. 1, pp. 63-75
Open Access | Times Cited: 10

Cancer screening in chronic inflammatory rheumatic diseases
Joanna Kedra, Raphaèle Séror
Joint Bone Spine (2023) Vol. 90, Iss. 4, pp. 105557-105557
Open Access | Times Cited: 4

Cancer Surveillance in Solid Organ Transplant Recipients With a Pretransplant History of Malignancy: Multidisciplinary Collaborative Expert Opinion
Kymberly D. Watt, Stacey Rolak, David P. Foley, et al.
Transplantation (2024) Vol. 108, Iss. 12, pp. 2336-2350
Closed Access | Times Cited: 1

Causal relationships between immune cell phenotypes and lung adenocarcinoma: A bidirectional two‐sample Mendelian randomization study
Bowen Li, Zhicheng Huang, Yadong Wang, et al.
Thoracic Cancer (2024) Vol. 15, Iss. 21, pp. 1673-1680
Open Access | Times Cited: 1

Clinical characteristics of renal cell carcinoma in the transplanted kidney in renal transplant recipients: a systematic scoping review
Manasawee Tanariyakul, Sakditad Saowapa, Noppawit Aiumtrakul, et al.
Baylor University Medical Center Proceedings (2024) Vol. 37, Iss. 5, pp. 832-838
Open Access | Times Cited: 1

Solid Organ Transplantation and Survival among Individuals with a History of Cancer
Eric A. Engels, Gregory Haber, Allyson Hart, et al.
Cancer Epidemiology Biomarkers & Prevention (2021) Vol. 30, Iss. 7, pp. 1312-1319
Open Access | Times Cited: 10

Page 1 - Next Page

Scroll to top